Phase 1b Safety, Tolerability, and PK Study to Assess GS-5737 in Subjects With CF

Clinical trial NCT01840735 · COMPLETED

Trial details

NCT number: NCT01840735
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2013-05-01
Primary completion: 2013-07-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.